InteRNA Presents Expanded Preclinical Proof-of-concept Data on Lead Oncology Development Candidate INT-1B3 at the 14th Annual OTS Meeting - InteRNA Technologies

InteRNA Presents Expanded Preclinical Proof-of-concept Data on Lead Oncology Development Candidate INT-1B3 at the 14th Annual OTS Meeting

Click here to read the InteRNA OTS Data Announcement

Click here to read InteRNA Poster #63 showing the data

Click here to read InteRNA Poster #114 showing the data